Topical Steroid Withdrawal is a Targetable Excess of Mitochondrial NAD+
Nadia Shobnam, Sarini Saksena, Grace Ratley, Manoj Yadav, Prem Prashant Chaudhary, Ashleigh A Sun, Katherine N Howe, Manasi Gadkari, Luis M Franco, Sundar Ganesan, Katelyn J McCann, Amy P Hsu, Kishore Kanakabandi, Stacy Ricklefs, Justin Lack, Weiming Yu, Morgan Similuk, Magdalena A Walkiewicz, NIAID Centralized Sequencing Program, Donna D Gardner, Kelly Barta, Kathryn Tullos, Ian A Myles
doi: https://doi.org/10.1101/2024.04.17.24305846
Nadia Shobnam
1Laboratory of Clinical Immunology and Microbiology (LCIM), Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda MD
Sarini Saksena
1Laboratory of Clinical Immunology and Microbiology (LCIM), Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda MD
Grace Ratley
1Laboratory of Clinical Immunology and Microbiology (LCIM), Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda MD
Manoj Yadav
1Laboratory of Clinical Immunology and Microbiology (LCIM), Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda MD
Prem Prashant Chaudhary
1Laboratory of Clinical Immunology and Microbiology (LCIM), Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda MD
Ashleigh A Sun
1Laboratory of Clinical Immunology and Microbiology (LCIM), Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda MD
Katherine N Howe
2LCIM, NIAID, NIH, Bethesda MD
Manasi Gadkari
3Functional Immunogenomics Section, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD
Luis M Franco
3Functional Immunogenomics Section, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD
Sundar Ganesan
4Biological Imaging Section, Research Technology Branch, NIAID, NIH, Bethesda, MD
Katelyn J McCann
3Functional Immunogenomics Section, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD
Amy P Hsu
3Functional Immunogenomics Section, Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD
Kishore Kanakabandi
5Genomic Research Section, Research Technologies Branch (RTB), Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT
Stacy Ricklefs
5Genomic Research Section, Research Technologies Branch (RTB), Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT
Justin Lack
6Integrated Data Science Section, RTB, NIAID, NIH, Bethesda, MD
Weiming Yu
6Integrated Data Science Section, RTB, NIAID, NIH, Bethesda, MD
Morgan Similuk
Magdalena A Walkiewicz
7Lymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD
Donna D Gardner
8Centralized Sequencing Program, Division of Intramural Research, NIAID, Bethesda, MD
Kelly Barta
9Allergy & Asthma Network, Fairfax, Virginia
Kathryn Tullos
9Allergy & Asthma Network, Fairfax, Virginia
Ian A Myles
1Laboratory of Clinical Immunology and Microbiology (LCIM), Epithelial Therapeutics Unit, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda MD
Posted April 19, 2024.
Topical Steroid Withdrawal is a Targetable Excess of Mitochondrial NAD+
Nadia Shobnam, Sarini Saksena, Grace Ratley, Manoj Yadav, Prem Prashant Chaudhary, Ashleigh A Sun, Katherine N Howe, Manasi Gadkari, Luis M Franco, Sundar Ganesan, Katelyn J McCann, Amy P Hsu, Kishore Kanakabandi, Stacy Ricklefs, Justin Lack, Weiming Yu, Morgan Similuk, Magdalena A Walkiewicz, NIAID Centralized Sequencing Program, Donna D Gardner, Kelly Barta, Kathryn Tullos, Ian A Myles
medRxiv 2024.04.17.24305846; doi: https://doi.org/10.1101/2024.04.17.24305846
Topical Steroid Withdrawal is a Targetable Excess of Mitochondrial NAD+
Nadia Shobnam, Sarini Saksena, Grace Ratley, Manoj Yadav, Prem Prashant Chaudhary, Ashleigh A Sun, Katherine N Howe, Manasi Gadkari, Luis M Franco, Sundar Ganesan, Katelyn J McCann, Amy P Hsu, Kishore Kanakabandi, Stacy Ricklefs, Justin Lack, Weiming Yu, Morgan Similuk, Magdalena A Walkiewicz, NIAID Centralized Sequencing Program, Donna D Gardner, Kelly Barta, Kathryn Tullos, Ian A Myles
medRxiv 2024.04.17.24305846; doi: https://doi.org/10.1101/2024.04.17.24305846
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4365)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2814)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4132)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6721)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)